Invention Grant
- Patent Title: Maytansinoid-based drug delivery systems
-
Application No.: US16768418Application Date: 2018-11-30
-
Publication No.: US11572373B2Publication Date: 2023-02-07
- Inventor: Felix Kratz , Khalid Abu Ajaj , Anna Warnecke , Friederike I. Nollmann , Stephan David Koester , Javier Garcia Fernandez , Lara Pes , Heidi-Kristin Walter , Johannes Pall Magnusson , Serghei Chercheja , Patricia Perez Galan , Federico Medda , Steffen Josef Daum
- Applicant: LADRX CORPORATION
- Applicant Address: US CA Los Angeles
- Assignee: LADRX CORPORATION
- Current Assignee: LADRX CORPORATION
- Current Assignee Address: US CA Los Angeles
- Agency: Haley Guiliano LLP
- Agent Karen Mangasarian; Mihaela Danca
- International Application: PCT/US2018/063380 WO 20181130
- International Announcement: WO2019/108975 WO 20190606
- Main IPC: C07D498/18
- IPC: C07D498/18 ; A61K31/537 ; A61P29/00 ; A61P31/00 ; A61P35/00 ; A61P37/00 ; A61K47/64
Abstract:
The present subject matter provides for albumin-binding prodrugs, maytansinoid-based compounds, and uses thereof.
Information query
